Rate Video

COMy Virtual 2020 | Targetting BCMA in myeloma

Saad Usmani • 13 May 2020

COMy Virtual 2020

Multiple Myeloma

Saad Usmani, MD, FACP, Levine Cancer Institute & Atrium Health, Charlotte, NC, touches on the rationale for targeting B-cell maturation antigen (BCMA) in multiple myeloma and the current therapeutic approaches. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Short-duration fixed-volume infusion of isatuximab in relapsed/refractory myeloma

Saad Usmani • 29 May 2020

DREAMM-9: belantamab mafodotin plus VRd vs VRd in TI NDMM

Saad Usmani • 27 May 2020

Immunotherapy in myeloma: current strategies and future perspectives

Ajai Chari et al. • 12 Sep 2019

The definitive guide to multiple myeloma at ASH 2018: part II

Mohamad Mohty et al.

Related Videos

Maintenance therapy in young patients with myeloma

Graham Jackson • 5 Mar 2021

BVD in heavily pretreated multiple myeloma

Claudio Cerchione • 3 Mar 2021

#woMMen: network of women in multiple myeloma

Nina Shah • 3 Mar 2021

Frailty subgroup analysis of the MAIA trial

Gordon Cook • 2 Mar 2021